Components:
Medically reviewed by Kovalenko Svetlana Olegovna, PharmD. Last updated on 21.06.2022
Attention! Information on this page is intended only for medical professionals! Information is collected in open sources and may contain significant errors! Be careful and double-check all the information on this page!
Top 20 medicines with the same components:
Solmux Capsule is a mucolytic agent for the adjunctive therapy of respiratory tract disorders characterised by excessive, viscous mucus, including chronic obstructive airways disease.
Capsule: Adult and Children ≥12 years: 1 capsule. Forte Suspension: Adult and Children ≥12 years: 5 mL (1 tsp). 100 mg/5 mL Pediatric Suspension: Children 8-12 years: 15 mL (3 tsp), 4-7 years: 10 mL (2 tsp), 2-3 years: 5 mL (1 tsp). 200 mg/5 mL Pediatric Suspension: Children 8-12 years: 7.5 mL, 4-7 years: 5 mL, 2-3 years: 2.5 mL. Infant
Oral Drops:
Infants 1-2 years: 1.5 mL. All doses to be taken orally every 8 hrs.Adult Syrup: Gastroduodenal ulceration.
Children Syrup: Known hypersensitivity to any of the components of Solmux Capsule Children Syrup, in particular to parabens. Children <2 years due to risk of worsening airway congestion.
Solmux Capsule is used along with other medications as adjunctive therapy to treat conditions of the respiratory tract which causes difficulty in breathing, including chronic obstructive airways disease.
mixing Solmux Capsule with pholcodine linctus causes precipitation of Solmux Capsule from solution but no information is given on whether this incompatibility is with the pholcodine or some component of the formulation used.
Capsules, Syrup and Paediatric Syrup:
Immune System Disorders
There have been reports of anaphylactic reactions and fixed drug eruption.
Skin and subcutaneous tissue disorders
There have been reports of skin rashes and allergic skin eruptions.
Capsules and Syrup:
Gastrointestinal disorders
There have been rare reports of gastrointestinal bleeding occurring during treatment with Solmux Capsule.
Solmux Capsule is a mucolytic that reduces the viscosity of sputum and so can be used to help relieve the symptoms of chronic obstructive pulmonary disorder (COPD) and bronchiectasis by allowing the sufferer to bring up sputum more easily. Solmux Capsule should not be used with antitussives (cough suppressants) or medicines that dry up bronchial secretions. Solmux Capsule is produced by alkylation of cysteine with chloroacetic acid.